A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://link.springer.com/doi/10.1007/s11605-009-0912-9 below:

Duodenal-Jejunal Exclusion Improves Glucose Tolerance in the Diabetic, Goto-Kakizaki Rat by a GLP-1 Receptor-Mediated Mechanism

References

  1. Livingston EH. Procedure incidence and in-hospital complication rates of bariatric surgery in the United States. Am J Surg 2004;188:105–110. doi:10.1016/j.amjsurg.2004.03.001.

    Article  PubMed  Google Scholar 

  2. Parikh M, Ayoung-Chee P, Romanos E, Lewis N, Pachter HL, Fielding G, Ren C. Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg 2007;205:631–635. doi:10.1016/j.jamcollsurg.2007.05.033.

    Article  PubMed  Google Scholar 

  3. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, Dohm L. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339–350. doi:10.1097/00000658-199509000-00011.

    Article  PubMed  CAS  Google Scholar 

  4. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467–484.

    PubMed  Google Scholar 

  5. Sjostrom CD, Lissner L, Wedel H, Sjostrom L. Reduction in incidence of diabetes, hypertension, and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999;7:477–484.

    PubMed  CAS  Google Scholar 

  6. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H, Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683–2693. doi:10.1056/NEJMoa035622.

    Article  PubMed  Google Scholar 

  7. Yan E, Ko E, Luong V, Wang HJ, Romanova M, Li Z. Long-term changes in weight loss and obesity-related comorbidities after Roux-en-Y gastric bypass: a primary care experience. Am J Surg 2008;195:94–98. doi:10.1016/j.amjsurg.2007.01.036.

    Article  PubMed  Google Scholar 

  8. Pories W, Albrecht R. Etiology of type II diabetes mellitus: role of the foregut. World J Surg 2001;25:527–531. doi:10.1007/s002680020348.

    Article  PubMed  CAS  Google Scholar 

  9. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M, Marescaux J. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244:741–749. doi:10.1097/01.sla.0000224726.61448.1b.

    Article  PubMed  Google Scholar 

  10. Morínigo R, Moizé V, Musri M, Lacy AM, Navarro S, Marín JL, Delgado S, Casamitjana R, Vidal J. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2006;91:1735–1740. doi:10.1210/jc.2005-0904.

    Article  PubMed  CAS  Google Scholar 

  11. Laferrere B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J, Hart AB, Olivan B. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007;30:1709–1716. doi:10.2337/dc06-1549.

    Article  PubMed  CAS  Google Scholar 

  12. Pacheco D, de Luis DA, Romero A, González Sagrado M, Conde R, Izaola O, Aller R, Delgado A. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg 2007;194:221–224. doi:10.1016/j.amjsurg.2006.11.015.

    Article  PubMed  CAS  Google Scholar 

  13. Troy S, Soty M, Ribeiro L, Laval L, Migrenne S, Fioramonti X, Pillot B, Fauveau V, Aubert R, Viollet B, Foretz M, Leclerc J, Duchampt A, Zitoun C, Thorens B, Magnan C, Mithieux G, Andreelli F. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 2008;8:177–179. doi:10.1016/j.cmet.2008.08.008.

    Article  CAS  Google Scholar 

  14. Bose M, Oliván B, Teixeira J, Pi-Sunyer FX, Laferrère B. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg 2009;19:217–229. doi:10.1007/s11695-008-9696-3.

    Article  PubMed  Google Scholar 

  15. Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab 1993;76:912–917. doi:10.1210/jc.76.4.912.

    Article  PubMed  CAS  Google Scholar 

  16. Drucker DJ. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 2003;26:2929–2940. doi:10.2337/diacare.26.10.2929.

    Article  PubMed  CAS  Google Scholar 

  17. Zander M, Madsbad S, Madsen JL, Holst JJ. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 2002;359:824–830. doi:10.1016/S0140-6736(02)07952-7.

    Article  PubMed  CAS  Google Scholar 

  18. Creutzfeldt WO, Kleine N, Willms B, Orskov C, Holst JJ, Nauck MA. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide 1(7-36) amide in type 1 diabetic patients. Diabetes Care 1996;19:580–586. doi:10.2337/diacare.19.6.580.

    Article  PubMed  CAS  Google Scholar 

  19. Ayala JE, Bracy DP, James FD, Julien BM, Wasserman DH, Drucker DJ. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action. Endocrinology 2008;PMID:19008308.

    Google Scholar 

  20. Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, Schmiegel WH. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol. 1997;273:E981–E988.

    PubMed  CAS  Google Scholar 

  21. Turton MD, O’Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996;379:69–72. doi:10.1038/379069a0.

    Article  PubMed  CAS  Google Scholar 

  22. Näslund E, Bogefors J, Skogar S, Grybäck P, Jacobsson H, Holst JJ, Hellström PM. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. Am J Physiol 1999;277:R910–R916.

    PubMed  Google Scholar 

  23. DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 2005;28:1092–1100. doi:10.2337/diacare.28.5.10920.

    Article  PubMed  CAS  Google Scholar 

  24. Aschner P, Kipnes MS, Lunceford JK, Sanchez M, Mickel C, Williams-Herman DE, Sitagliptin Study 021 Group. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care 2006;29:2632–2637. doi:10.2337/dc06-0703.

    Article  PubMed  CAS  Google Scholar 

  25. Goldstein BJ, Feinglos MN, Lunceford JK, Johnson J, Williams-Herman DE, Sitagliptin 036 Study Group. Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes. Diabetes Care 2007;30:1979–1987. doi:10.2337/dc07-0627.

    Article  PubMed  CAS  Google Scholar 

  26. Rodieux F, Giusti V, D’Alessio DA, Suter M, Tappy L. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) 2008;16:298–305. doi:10.1038/oby.2007.83.

    Article  CAS  Google Scholar 

  27. Vidal J, Nicolau J, Romero F, Casamitjana R, Momblan D, Conget I, Morínigo R, Lacy AM. Long-term effects of Roux-en-y gastric bypass surgery on plasma GLP-1 and islet function in morbidly obese subjects. J Clin Endocrinol Metab 2008;PMID:19106269.

    Google Scholar 

  28. le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, Lönroth H, Fändriks L, Ghatei MA, Bloom SR, Olbers T. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007;246:780–785. doi:10.1097/SLA.0b013e3180caa3e3.

    Article  PubMed  Google Scholar 

  29. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004;239:1–11. doi:10.1097/01.sla.0000102989.54824.fc.

    Article  PubMed  Google Scholar 

  30. Koopmans HS, Sclafani A, Fichtner C, Aravich PF. The effects of ileal transposition on food intake and body weight loss in VMH-obese rats. Am J Clin Nutr 1982;35:284–293.

    PubMed  CAS  Google Scholar 

  31. Strader A, Vahl T, Jandacek R, Woods S, D’Alessio D, Seeley R. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rat. Am J Physiol Endocrinol Metab 2005;288:E447–E453. doi:10.1152/ajpendo.00153.2004.

    Article  PubMed  CAS  Google Scholar 

  32. Stader A, Clausen TR, Goodin SZ, Wendt D. Ileal interposition improves glucose tolerance in low dose streptozocin-treated diabetic and euglycemic rats. Obes Surg 2009;19:96–104. doi:10.1007/s11695-008-9754-x.

    Article  Google Scholar 

  33. Patriti A, Facchiano E, Annetti C, Aisa MC, Galli F, Fanelli C, Donini A. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg 2005;15:1258–1264. doi:10.1381/096089205774512573.

    Article  PubMed  Google Scholar 

  34. Wang TT, Hu SY, Gao HD, Zhang GY, Liu CZ, Feng JB, Frezza EE. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg 2008;247:968–975. doi:10.1097/SLA.0b013e318172504d.

    Article  PubMed  Google Scholar 

  35. Kindel TL, Yang Q, Yoder SY, Tso P. Nutrient-driven lymphatic incretin secretion is different between diabetic, Goto-Kakizaki rats and Wistar rats. Am J Physiol Gastrointest Liver Physiol 2009;296:G168–G174. doi:10.1152/ajpgi.90506.2008.

    Article  PubMed  CAS  Google Scholar 

  36. Thorens B. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci U S A 1992;89:8641–8645. doi:10.1073/pnas.89.18.8641.

    Article  PubMed  CAS  Google Scholar 

  37. Shughrue PJ, Lane MV, Merchenthaler I. Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology 1996;137:5159–5162. doi:10.1210/en.137.11.5159.

    Article  PubMed  CAS  Google Scholar 

  38. Dunphy JL, Taylor RG, Fuller PJ. Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression. Mol Cell Endocrinol 1998;141:179–186. doi:10.1016/S0303-7207(98)00096-3.

    Article  PubMed  CAS  Google Scholar 

  39. Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL, Wardlaw SL. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 2005;90:359–365. doi:10.1210/jc.2004-1076.

    Article  PubMed  CAS  Google Scholar 

  40. Korner J, Inabnet W, Conwell IM, Taveras C, Daud A, Olivero-Rivera L, Restuccia NL, Bessler M. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring) 2006;14:1553–1561. doi:10.1038/oby.2006.179.

    Article  CAS  Google Scholar 

  41. Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshy N, Lee H, Yapp K, Olivan B. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008;93:2479–2485. doi:10.1210/jc.2007-2851.

    Article  PubMed  CAS  Google Scholar 

  42. Korner J, Bessler M, Inabnet W, Taveras C, Holst JJ. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 2007;3:597–601. doi:10.1016/j.soard.2007.08.004.

    Article  PubMed  Google Scholar 

  43. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E. The early effect of the Roux-en-Y Gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004;240:236–242. doi:10.1097/01.sla.0000133117.12646.48.

    Article  PubMed  Google Scholar 

  44. Swarbrick MM, Stanhope KL, Austrheim-Smith IT, Van Loan MD, Ali MR, Wolfe BM, Havel PJ. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 2008;51:1901–1911. doi:10.1007/s00125-008-1118-5.

    Article  PubMed  CAS  Google Scholar 

  45. Wang Z, Wang RM, Owji AA, Smith DM, Ghatei MA, Bloom SR. Glucagon-like peptide-1 is a physiologic incretin in rat. J Clin Invest 1995;95:417–421. doi:10.1172/JCI117671.

    Article  PubMed  CAS  Google Scholar 

  46. Kolligs F, Fehmann HC, Goke R, Goke B. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. Diabetes 1995;44:16–19. doi:10.2337/diabetes.44.1.16.

    Article  PubMed  CAS  Google Scholar 

  47. Parlevliet ET, Heijboer AC, Schröder-van der Elst JP, Havekes LM, Romijn JA, Pijl H, Corssmit EP. Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet. Am J Physiol Endocrinol Metab 2008;294:E142–E147. doi:10.1152/ajpendo.00576.2007.

    Article  PubMed  CAS  Google Scholar 

  48. Maida A, Lovshin JA, Baggio LL, Drucker DJ. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice. Endocrinology 2008;149:5670–5678. doi:10.1210/en.2008-0336.

    Article  PubMed  CAS  Google Scholar 

  49. Bikman BT, Zheng D, Pories WJ, Chapman W, Pender JR, Bowden RC, Reed MA, Cortright RN, Tapscott EB, Houmard JA, Tanner CJ, Lee J, Dohm GL. Mechanism for improved insulin sensitivity after gastric bypass surgery. J Clin Endocrinol Metab 2008;93:4656–4663. doi:10.1210/jc.2008-1030.

    Article  PubMed  CAS  Google Scholar 

  50. Ballantyne GH, Farkas D, Laker S, Wasielewski A. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg 2006;16:1189–1197. doi:10.1381/096089206778392158.

    Article  PubMed  CAS  Google Scholar 

  51. Lee WJ, Lee YC, Ser KH, Chen JC, Chen SC. Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures. Obes Surg 2008;18:1119–1125. doi:10.1007/s11695-008-9457-3.

    Article  PubMed  Google Scholar 

  52. Movassat J, Calderari S, Fernández E, Martín MA, Escrivá F, Plachot C, Gangnerau MN, Serradas P, Alvarez C, Portha B. Type 2 diabetes- a matter of failing β-cell neogenesis? Clues from the GK rat model. Diabetes Obes Metab 2007;9s2:187–195.

    Article  CAS  Google Scholar 

  53. Goto Y, Kakizaki M, Masaski N. Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 1976;119:85–90.

    Article  PubMed  CAS  Google Scholar 

  54. Kimura K, Toyota T, Kakizaki M, Kudo M, Takebe K, Goto Y. Impaired insulin secretion in the spontaneous diabetes rats. Tohoku J Exp Med 1982;137:453–459. doi:10.1620/tjem.137.453.

    Article  PubMed  CAS  Google Scholar 

  55. Giroix MH, Vesco L, Portha B. Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes. Endocrinology 1993;132:815–822. doi:10.1210/en.132.2.815.

    Article  PubMed  CAS  Google Scholar 

  56. Homo-Delarche F, Calderari S, Irminger JC, Gangnerau MN, Coulaud J, Rickenbach K, Dolz M, Halban P, Portha B, Serradas P. Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes 2006;55:1625–1633. doi:10.2337/db05-1526.

    Article  PubMed  CAS  Google Scholar 

  57. Smith BR, Hinojosa MW, Reavis KM, Nguyen NT. Remission of diabetes after laparoscopic gastric bypass. Am Surg 2008;74:948–952.

    PubMed  Google Scholar 

  58. Patriti A, Aisa MC, Annetti C, Sidoni A, Galli F, Ferri I, Gullà N, Donini A. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-Kakizaki rats through an enhanced Proglucagon gene expression and L-cell number. Surgery 2007;142:74–85. doi:10.1016/j.surg.2007.03.001.

    Article  PubMed  Google Scholar 

  59. Fineman MS, Bicsak TA, Shen LZ, Taylor K, Gaines E, Varns A, Kim D, Baron AD. Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes. Diabetes Care 2003;26:2370–2377. doi:10.2337/diacare.26.8.2370.

    Article  PubMed  CAS  Google Scholar 

Download references

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.4